Filing Flows › National Health Investors (NHI) › Q1 2026 › vs Q1 2025
National Health Investors (NHI) Q1 2026 vs Q1 2025 (year over year)
National Health Investors's revenue rose $25.8M (+29%) from $89.3M in Q1 2025 to $115M in Q1 2026. Operating margin 34.5% against 37.9% (-3.3 pts).
National Health Investors, Q1 2026: revenue $115M (+29% year over year), operating margin 34.5%, net earnings $40.1M, operating cash flow $53.4M. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Operating margin | 34.5% | 37.9% | -3.3 pts |
| Net margin | 34.8% | 38.3% | -3.4 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $115M | $89.3M | $25.8M | +29% |
| Operating profit | $39.8M | $33.8M | $5.9M | +18% |
| Costs & expenses | $75.4M | $55.5M | $19.9M | +36% |
| Pre-tax earnings | $39.8M | $33.8M | $5.9M | +18% |
| General & admin | $7.9M | $6.8M | $1.0M | +15% |
| Other operating costs | $67.5M | $48.6M | $18.9M | +39% |
| Loss borne by minority interests | $350K | $348K | $2K | +0.6% |
| Net earnings | $40.1M | $34.2M | $5.9M | +17% |
| Depreciation & amortization | $23.7M | $19.2M | $4.5M | +24% |
| Share-based compensation | $2.2M | $2.6M | −$318K | -12% |
| Working capital & other | $12.6M | $9.4M | $3.2M | +34% |
| Operating cash flow | $53.4M | $46.5M | $7.0M | +15% |
| Capital expenditures | $109M | $85.2M | $24.3M | +28% |
| Negative free cash flow (OCF − capex) | $56.0M | $38.7M | $17.3M | +45% |
Questions
How much did National Health Investors's revenue grow year over year in Q1 2026?
National Health Investors's revenue rose $25.8M (+29%) from $89.3M in Q1 2025 to $115M in Q1 2026. Operating margin 34.5% against 37.9% (-3.3 pts).